Invention Grant
- Patent Title: Sirtuin modulating compounds
- Patent Title (中): 沉默调节蛋白调节化合物
-
Application No.: US13012775Application Date: 2011-01-24
-
Publication No.: US08268862B2Publication Date: 2012-09-18
- Inventor: Jean Bemis , Jeremy S. Disch , Pui Yee Ng , Christopher Oalmann , Robert B. Perni , Chi B. Vu
- Applicant: Jean Bemis , Jeremy S. Disch , Pui Yee Ng , Christopher Oalmann , Robert B. Perni , Chi B. Vu
- Applicant Address: US MA Cambridge
- Assignee: Sirtris Pharmaceuticals, Inc.
- Current Assignee: Sirtris Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Ropes & Gray LLP
- Agent James T. Olesen; Jeffrey A. Sutton
- Main IPC: A61K31/44
- IPC: A61K31/44 ; A61K31/425 ; A61K31/385 ; A61K31/38

Abstract:
Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
Public/Granted literature
- US20110152254A1 SIRTUIN MODULATING COMPOUNDS Public/Granted day:2011-06-23
Information query